Developing Story: Your Cancer's DNA and the Trial Using It to Cure You with Dr. Pedram Razavi
What does it take to cure metastatic breast cancer? According to Dr. Pedram Razavi, it takes a blood test sensitive enough to find one cancer cell in a million, the courage to stop treatment when that signal disappears, and a trial designed to prove the paradigm wrong.
The HERizon-Breast Trial at Memorial Sloan Kettering is doing exactly that — and it's enrolling now.
This is one of the most science-rich episodes of Live from Stage 4 to date. We break down every term, every concept, and every implication in plain language so you don't need a medical degree to understand why this matters.
Developing Story: The Trial That Dares to Say Cure with Dr. Lior Braunstein
Dr. Lior Braunstein, radiation oncologist at Memorial Sloan Kettering, joins Victoria Goldberg and Ellen Landsberger to discuss the ARCHER trial — a groundbreaking study combining surgery and ablative radiation with standard HER2-targeted therapy in patients with oligometastatic HER2-positive breast cancer. The goal: eradicate every last cancer cell before resistance can emerge.